# Commission Decision of 11 April 2007 concerning the extension of the deadline for placing on the market of biocidal products containing certain active substances not examined during the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council (notified under document number C(2007) 1545) (Only the French and Polish texts are authentic) (2007/226/EC), Article 2

Extent: E+W+S+N.I.

1. Member States making use of the derogation provided for in Article 1 of this Decision shall ensure that the following conditions are complied with:
(a) continued use is only possible under the conditions that products containing the substance are approved for the intended essential use;
(b) the continued use is only accepted so far as it has no unacceptable effect on human or animal health or on the environment;
(c) all appropriate risk reduction measures are imposed when granting approval;
(d) such biocidal products remaining on the market after 1 September 2006 are relabelled in order to match the restricted use conditions;
(e) where appropriate, Member States shall ensure that alternatives for such uses are being sought by the holders of the approvals or by the Member States concerned, or that a dossier is being prepared for submission in accordance with the procedure laid down in Article 11 of Directive 98/8/EC by 14 May 2008 at the latest.
2. Where appropriate, the Member States concerned shall inform the Commission annually on the application of paragraph 1 and in particular on the actions taken pursuant to point (e).

---
Source: https://www.legislation.gov.uk/eudn/2007/226/article/2 (the official version)
Page: https://openlegislation.uk/eu-decision-2007-226/article-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.